Specialists for Cutaneous neuroendocrine carcinoma

60 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Shailender Bhatia, MD
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
SEATTLE, WA
QC-verified PI×2
Christoper Barker, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
QC-verified PI×1
Shailender Bhatia, MD, MD
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
SEATTLE, WA
QC-verified PI×1
Amanda Olson
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
PI×2 19
Jason J Luke
Rare Disease Specialist
Alliance for Clinical Trials in Oncology
Philadelphia, Pennsylvania
PI×4
Andrew Brohl, MD, M.D
Rare Disease / Clinical Research
Moffitt Cancer Center
TAMPA, FL
PI×2 1
Karam Khaddour, MD, MD
Rare Disease / Clinical Research
Dana-Farber Cancer Institute
BOSTON, MA
PI×1
Ciara Kelly, MBBCh BAO
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
PI×2 9
John Miura, MD, M.D
Rare Disease / Clinical Research
Penn Medicine
PHILADELPHIA, PA
PI×1
Erez Baruch, MD,PHD, MD, PhD
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×1
Ann (Annie) W Silk
Rare Disease Specialist
Dana-Farber - Harvard Cancer Center LAO
Los Angeles, California
PI×1
Timothy A Yap, MD, MD
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×1
Dan Zandberg, MD, MD
Rare Disease / Clinical Research
UPMC Hillman Cancer Center
BALTIMORE, MD
PI×2
K Mosterd, MD, PhD
Rare Disease / Clinical Research
Maastricht University Medical Center
PI×4
Lara Dunn, MD, SLP
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
GOLDEN, CO
PI×1
Nina Merchant
Rare Disease / Clinical Research
Medicenna Therapeutics
PI×1
Joshua Veatch, M.D., Ph.D
Rare Disease / Clinical Research
Fred Hutch/University of Washington Cancer Consortium
SEATTLE, WA
PI×2
Claire Verschraegen, MD, MD
Rare Disease / Clinical Research
Ohio State University Comprehensive Cancer Center
COLUMBUS, OH
PI×2
Laurent Mortier, MD,PhD
Rare Disease / Clinical Research
University Hospital, Lille
PI×2
Julian R. Molina, M.D., Ph.D.
Rare Disease / Clinical Research
Mayo Clinic
PI×1
Fred Hausheer, MD, FACP
Rare Disease / Clinical Research
Elephas
PI×2
Vincent Ma, MD
Rare Disease / Clinical Research
University of Wisconsin, Madison
PI×3
Bret Goodpaster, PhD
Rare Disease / Clinical Research
Translational Research Institute for Metabolism and Diabetes
PI×3
Nawel Bourayou, MD
Rare Disease / Clinical Research
Incyte Corporation
PI×2
Mahtab SAMIMI, MD-PhD
Rare Disease / Clinical Research
University Hospital, Tours
PI×2
Sergey V. Orlov, Professor
Rare Disease / Clinical Research
EuroCityClinic LLC
PI×1
Mojun Zhu, M.D., M.D
Rare Disease / Clinical Research
Mayo Clinic in Rochester
ROCHESTER, MN
PI×1
Joanna Ludzik, MD, MD, PhD
Rare Disease / Clinical Research
OHSU Knight Cancer Institute
PORTLAND, OR
PI×1
Michael Poulsen, PharmD
Trans Tasman Radiation Oncology Group
ROCKFORD, IL
QC-verified PI×1
John Goldberg
Oncorus, Inc.
QC-verified PI×1
Ryan C DeCoste
Rare Disease / Clinical Research
QEII Health Science Centre
2
Michael D Carter
Rare Disease / Clinical Research
Queen Elizabeth II Health Sciences Centre
2
Sylvia Pasternak
Rare Disease / Clinical Research
Queen Elizabeth II Health Sciences Centre
2
Tomoko Akaike, MD
Rare Disease / Clinical Research
University of Washington
SEATTLE, WA
2
Monique E Verhaegen
Rare Disease / Clinical Research
University of Michigan
2
Kaitlin Vanderbeck
Rare Disease / Clinical Research
University of Texas
HOUSTON, TX
2
Kim Margolin, MD
Providence Saint John's Cancer Institute
SANTA MONICA, CA
QC-verified PI×2
Paul Nghiem
Fred Hutchinson Cancer Center
SEATTLE, WA
QC-verified PI×2
Bobby Reddy, M.D
ImmunityBio, Inc.
BOSTON, MA
QC-verified PI×1
Paul W Harms, M.D
Rare Disease / Clinical Research
University of Michigan
ANN ARBOR, MI
2
Linda Mahoney, LCDP, CDCS
Phio Pharmaceuticals Inc.
WYOMING, RI
QC-verified PI×1
Claire F Verschraegen, MD
Ohio State University Comprehensive Cancer Center
COLUMBUS, OH
QC-verified PI×1
Lynn Dengel, MD
Rare Disease / Clinical Research
University of Virginia
CHARLOTTESVILLE, VA
PI×1
Neal Ready, MD
Rare Disease / Clinical Research
Duke Cancer Institute
DURHAM, NC
PI×1
Noreen M Walsh
Rare Disease / Clinical Research
Queen Elizabeth II Health Sciences Centre
SPRINGFIELD, MA
2
Thai Yen Ly, ARNP
Rare Disease / Clinical Research
Queen Elizabeth II Health Sciences Centre
TACOMA, WA
2
Aude Chapuis, MD
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
SEATTLE, WA
QC-verified PI×4
Salah Al-Batran
Krankenhaus Nordwest
QC-verified PI×4
Michael B Gill
Power Life Sciences Inc.
QC-verified PI×22
Rainer Hofmann-Wellenhof
Department of Dermatology, Medical University of Graz
QC-verified PI×2
Robert Haddad
Dana-Farber Cancer Institute
QC-verified PI×2
Andrew S Brohl, M.D
Collaborator
TAMPA, FL
QC-verified PI×2
William H McCoy IV
Washington University School of Medicine
QC-verified PI×1
Neil Steven
University of Birmingham
QC-verified PI×1
Prof Shahneen Sandhu
Peter MacCallum Cancer Centre, Australia
QC-verified PI×1
Evan Wuthrick, M.D
H. Lee Moffitt Cancer Center and Research Institute
QC-verified PI×1
Janice Mehnert
ECOG-ACRIN Cancer Research Group
NEW YORK, NY
QC-verified PI×1
Rishi Jain
SystImmune Inc.
CHICAGO, IL
QC-verified PI×1
Astrid Blom
Dermato-oncology Department, Ambroise Paré Hospital, APHP
QC-verified PI×1
Jürgen C. Becker
Medical University of Graz, Austria
QC-verified PI×1

More about Cutaneous neuroendocrine carcinoma

Disease overview →
Treatments →
Clinical trials →